🩹 Atopic Dermatitis (Eczema)

FDA-Approved Biologic Treatment Options · Insurance & Savings · Free Delivery

About Atopic Dermatitis (Eczema)

Atopic dermatitis (eczema) is the most common chronic inflammatory skin disease, affecting over 16 million adults in the United States. It is driven by a type 2 immune response and causes intensely itchy, inflamed, and dry skin that significantly impacts quality of life.

Common Symptoms

Intense itching (pruritis), often worse at night
Dry, cracked, scaly skin
Red to brownish-gray patches
Small, raised bumps that may weep fluid
Thickened, cracked skin (lichenification)
Skin infections from scratching
Sleep disruption due to itching

Insurance & Savings for Atopic Dermatitis (Eczema) Biologics

🛡️ Commercial Insurance

Most insured patients pay $0–$35/month through manufacturer copay programs. BiologicHealthPlus verifies your benefits at no charge.

🆓 Patient Assistance

Uninsured or income-eligible patients may receive biologic medications free of charge through manufacturer PAP programs.

📋 Prior Authorization

We file and manage all prior authorizations and insurance appeals for Atopic Dermatitis (Eczema) biologics — completely free.

✅ BiologicHealthPlus Handles Everything

Insurance verification · Prior authorization · Copay enrollment · Free cold-chain delivery to all 50 states · 24/7 pharmacist support

Check my coverage →

💊 FDA-Approved Biologics for Eczema / AD

Dupixent (Dupilumab) Rinvoq (Upadacitinib) Adbry (Tralokinumab) Ebglyss (Lebrikizumab)

Check My Coverage →

📞 Call a Pharmacist

Biologic Medications for Atopic Dermatitis (Eczema)

BiologicHealthPlus carries all FDA-approved biologic medications for Atopic Dermatitis (Eczema). Click any medication to learn about dosage, mechanism, storage, costs, and savings programs.

Browse All Medications →

Frequently Asked Questions About Atopic Dermatitis (Eczema)

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by a defective skin barrier and a dysregulated type 2 immune response driven by IL-4 and IL-13. It is closely associated with asthma, allergic rhinitis, and food allergies (the 'atopic march'). Moderate-to-severe AD often requires systemic or biologic treatment.

FDA-approved biologics for moderate-to-severe atopic dermatitis include Dupixent (Dupilumab), which blocks IL-4 and IL-13; Adbry (Tralokinumab), which targets IL-13; and Ebglyss (Lebrikizumab), another IL-13 inhibitor. Rinvoq (Upadacitinib), a JAK1 inhibitor, is also FDA-approved for AD.

The cash list price for Dupixent is approximately $3,500–$4,500/month. With commercial insurance and the Dupixent MyWay savings program, most insured patients pay $0–$35/month. Uninsured patients may qualify for free medication through patient assistance programs. BiologicHealthPlus enrolls every patient in all available savings.

Many patients see significant itch relief within 2 weeks and meaningful skin improvement by week 4–8. Clinical trial data shows continued improvement through 16 weeks and beyond.

Yes. BiologicHealthPlus ships Dupixent and other eczema biologics in free cold-chain packaging to all 50 states.

Free Cold-Chain Delivery for Atopic Dermatitis (Eczema) Medications

🚚 Free Delivery

All Atopic Dermatitis (Eczema) biologics ship free in temperature-controlled packaging to all 50 states.

⏱️ Fast Turnaround

Most prescriptions are processed and shipped within 1–2 business days of insurance verification.

🌡️ Temperature Guaranteed

Our cold-chain packaging maintains the required 36°F–46°F throughout transit.

💬 24/7 Support

BiologicHealthPlus pharmacists are available 24/7 by phone, WhatsApp, and email.

Many autoimmune conditions are related and share treatment options. Explore:

Plaque Psoriasis · Asthma · Hidradenitis Suppurativa

📚 Sources & Further Reading

BiologicHealthPlus follows medical consensus from leading health organizations. The following authoritative sources were used in developing this page:

🔗

Atopic DermatitisAAD

🔗

About Atopic DermatitisNational Eczema Association

🔗

Atopic DermatitisWikipedia

🔗

AD Clinical ReviewNIH / NCBI

Medical Disclaimer: Content is for educational purposes only and reviewed by the BiologicHealthPlus Clinical Team. Always consult your healthcare provider for personalized medical advice. Last reviewed: August 2026.

Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions. Last reviewed: July 2026 by the BiologicHealthPlus Clinical Team.